Supercoiling in prokaryotic and eukaryotic DNA: changes in response to topological perturbation of plasmids in E. coli and SV40 in vitro, in nuclei and in CV-1 cells.
Changes in DNA linking number have been observed in plasmid DNA purified from E. coli cells after the cells were treated with chloroquine. Chloroquine, a DNA intercalating drug, unwinds the DNA, decreasing the levels of negative supercoiling. Following this in vivo topological perturbation, within minutes DNA gyrase decreases DNA linking number producing more negatively supercoiled DNA topoisomers. Following the removal of the drug from cells, within minutes topoisomerase 1 or DNA gyrase increases the linking number restoring the original level of supercoiling. Analogous changes in DNA linking number after addition of chloroquine are observed in purified plasmid DNA, and in purified SV40 minichromosomes in the presence of exogenous topoisomerase. Changes in linking number are also observed in SV40 chromosomes in isolated nuclei and in SV40 DNA purified from CV-1 cells following topological perturbation with chloroquine. These results suggest that eukaryotic cells may have mechanisms to maintain a defined level of DNA supercoiling.
D000818:Animals; D002460:Cell Line; D002738:Chloroquine / Q000494:pharmacology; D004247:DNA; D004269:DNA, Bacterial / Q000187:drug effects; D004278:DNA, Superhelical; D004279:DNA, Viral; D004926:Escherichia coli / Q000235:genetics; D009154:Mutation; D009690:Nucleic Acid Conformation; D010957:Plasmids / Q000187:drug effects; D013539:Simian virus 40 / Q000235:genetics
D004269:DNA, Bacterial; D004278:DNA, Superhelical; D004279:DNA, Viral; D002738:Chloroquine; D004247:DNA